Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Vision and MET[original query] |
---|
Analysis of three pigment epithelium-derived factor gene polymorphisms in patients with exudative age-related macular degeneration. Molecular vision 2009 15 343-8. Mattes Dietmar, Haas Anton, Renner Wilfried, Steinbrugger Iris, El-Shabrawi Yosuf, Wedrich Andreas, Werner Christoph, Schmut Otto, Weger Mart |
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
![]() Translational psychiatry 2012 2 e129. Adkins D E, Clark S L, Åberg K, Hettema J M, Bukszár J, McClay J L, Souza R P, van den Oord E J C |
Paradoxical visuomotor adaptation to reversed visual input is predicted by BDNF Val66Met polymorphism. Journal of vision 2014 14 (9): . Barton Brian, Treister Andrew, Humphrey Melanie, Abedi Garen, Cramer Steven C, Brewer Alyssa |
TBK1 gene duplication and normal-tension glaucoma. JAMA ophthalmology 2014 May 132 (5): 544-8. Ritch Robert, Darbro Ben, Menon Geeta, Khanna Cheryl L, Solivan-Timpe Frances, Roos Ben R, Sarfarzi Mansoor, Kawase Kazuhide, Yamamoto Tetsuya, Robin Alan L, Lotery Andrew J, Fingert John |
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial. European journal of cancer (Oxford, England : 1990) 2017 11 87 147-163. Schöffski Patrick, Wozniak Agnieszka, Escudier Bernard, Rutkowski Piotr, Anthoney Alan, Bauer Sebastian, Sufliarsky Jozef, van Herpen Carla, Lindner Lars H, Grünwald Viktor, Zakotnik Branko, Lerut Evelyne, Debiec-Rychter Maria, Marréaud Sandrine, Lia Michela, Raveloarivahy Tiana, Collette Sandra, Albiges Lauren |
FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 8 28 (2): 249-254. Mathieu Luckson N, Larkins Erin, Akinboro Oladimeji, Roy Pourab, Amatya Anup K, Fiero Mallorie H, Mishra-Kalyani Pallavi S, Helms Whitney S, Myers Claire E, Skinner Amy M, Aungst Stephanie, Jin Runyan, Zhao Hong, Xia Huiming, Zirkelbach Jeanne Fourie, Bi Youwei, Li Yangbing, Liu Jiang, Grimstein Manuela, Zhang Xinyuan, Woods Stacie, Reece Kelie, Abukhdeir Abdelrahmman M, Ghosh Soma, Philip Reena, Tang Shenghui, Goldberg Kirsten B, Pazdur Richard, Beaver Julia A, Singh Harpre |
Clinical albinism score, presence of nystagmus and optic nerves defects are correlated with visual outcome in patients with oculocutaneous albinism. Ophthalmic genetics 2021 7 42 (5): 539-552. Dumitrescu Alina V, Tran Johnny, Pfeifer Wanda, Bhattarai Sajag V, Kemerley Andrew, Dunn Taylor V, Wang Kai, Scheetz Tod E, Drack Arle |
Genetic causes of nystagmus, foveal hypoplasia and subnormal visual acuity- other than albinism. Ophthalmic genetics 2021 2 42 (3): 243-251. Ehrenberg Miriam, Bagdonite-Bejarano Laura, Fulton Anne B, Orenstein Naama, Yahalom Claud |
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring MET Exon 14 Skipping. JCO precision oncology 2021 12 5 . Le Xiuning, Hong Lingzhi, Hensel Chuck, Chen Rongrong, Kemp Haley, Coleman Niamh, Ciunci Christine A, Liu Stephen V, Negrao Marcelo V, Yen Jennifer, Xia Xuefeng, Scheuenpflug Juergen, Stroh Christopher, Juraeva Dilafruz, Tsao Anne, Hong David, Raymond Victoria, Paik Paul, Zhang Jianjun, Heymach John |
Matching-Adjusted Indirect Comparison (MAIC) of Tepotinib with Other MET Inhibitors for the Treatment of Advanced NSCLC with MET Exon 14 Skipping Mutations. Advances in therapy 2022 5 39 (7): 3159-3179. Paik Paul K, Pfeiffer Boris M, Vioix Helene, Garcia Andrea, Postma Maarten |
Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia. Journal of child and adolescent psychopharmacology 2022 10 32 (8): 434-443. Riccobene Todd, Riesenberg Robert, Yeung Paul P, Earley Willie R, Hankinson Arlene |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 30, 2023
- Content source: